Quantum-Si (QSIAW) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

Quantum-Si

NASDAQ: QSIAW · Real-Time Price · USD
0.48
-0.11 (-18.09%)
At close: Jul 29, 2025, 3:50 PM

Company Description

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.

The company was founded in 2013 is headquartered in Branford, Connecticut.

Quantum-Si
Quantum-Si logo
Country United States
IPO Date n/a
Industry Biotechnology
Sector Healthcare
Employees 149
CEO Jeffrey Alan Hawkins

Contact Details

Address:
29 Business Park Drive
Branford, Delaware
United States
Website https://www.quantum-si.com

Stock Details

Ticker Symbol QSIAW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001816431
CUSIP Number 74765K113
ISIN Number US74765K1135
Employer ID 85-1388175
SIC Code 3829

Key Executives

Name Position
Jeffrey Alan Hawkins President, Chief Executive Officer & Director
Jeffry R. Keyes CPA Chief Financial Officer & Treasurer
Todd Rearick Chief Technology Officer
Dr. Christian Lapointe J.D., Ph.D. General Counsel & Corporate Secretary
Dr. John S. Vieceli Ph.D. Chief Product Officer
Dr. Jonathan M. Rothberg Ph.D. Founder & Executive Director
Katherine Atkinson Senior Vice President of Demand Generation & Corporate Brand
Lindsay Thompson Chief Human Resources Officer
Todd C. Bennett Chief Commercial Officer

Latest SEC Filings

Date Type Title
Jul 07, 2025 8-K Current Report
Jul 07, 2025 424B5 Filing
Jul 07, 2025 424B5 Filing
Jun 24, 2025 4 Filing
Jun 24, 2025 4 Filing
Jun 24, 2025 4 Filing
Jun 24, 2025 4 Filing
Jun 06, 2025 SCHEDULE 13G/A [Amend] Filing
May 22, 2025 SD Filing
May 21, 2025 4 Filing